LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)

June 5, 2025 updated by: LinkBio Corp.
To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.

Study Overview

Status

Enrolling by invitation

Detailed Description

The study will collect outcomes data on up to 600 patients from up to 3 sites using a legally marketed device according to its labeled intended use.

The study will collect:

  1. KOOS-JR
  2. Knee Society Score (KSS), 2011
  3. PROMIS Global Health
  4. PROMIS Physical Function
  5. PROMIS Pain Interference
  6. Surgery Satisfaction
  7. Forgotten Joint Score
  8. Radiographic findings
  9. Revisions.

Radiographic evaluations will be done through postoperative year 2. Other outcomes will be evaluated up to postoperative year 5.

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35235
        • OrthoAlabama Spine & Sports
    • Illinois
      • Libertyville, Illinois, United States, 60048
        • Illinois Bone and Joint Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients seeking primary total knee arthroplasty from the participating surgeon investigators

Description

Inclusion Criteria:

  • 18 years or older, and skeletally mature; and
  • Undergoing a primary TKA for one or both knees using the cemented LinkSymphoKnee knee system as part of the surgeon's standard of care.
  • Able to read and understand English (because patient-reported outcome questionnaires are not validated for all potential other languages).

Exclusion Criteria:

  • 80 years of age or older,
  • Women who are pregnant at the time of surgery,
  • History of joint sepsis,
  • Bone defect that requires grafting,
  • Previous history of bone disease (e.g., severe osteoporosis or osteomalacia) which in the surgeon's opinion is severe enough to compromise device fixation,
  • Systemic conditions affecting bone density (e.g., inflammatory arthritis or renal disease) which in the surgeon's opinion are severe enough to compromise device fixation,
  • A poorly functioning contralateral total knee replacement or a contralateral revision regardless of function.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revision rate
Time Frame: 5 years postoperative
Evaluates how often patients require additional surgery to remove or replace the knee arthroplasty device components.
5 years postoperative
Knee Injury and Osteoarthritis Outcome Score - Joint Replacement (KOOS-JR) - change from baseline
Time Frame: 1 year postoperative
Patient-reported outcome measure (PROM) that assesses knee health based on questions about pain, stiffness, function, and daily activities. Minimum score = 0. Maximum score = 100. Higher score means a better outcome.
1 year postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score - change from baseline
Time Frame: postoperative intervals through 5 years
A rating scale that measures the outcome of a patient's knee replacement surgery by assessing objective and subjective outcomes, including pain, range of motion, stability, walking distance, and ability to climb stairs, and also patient satisfaction and expectations. Minimum score = 0. Maximum score = 100. Higher score means better outcome.
postoperative intervals through 5 years
PROMIS Global Health Score - change from baseline
Time Frame: postoperative intervals through 5 years
PROMIS Global Health measures physical function, pain, fatigue, emotional distress, and social health. The raw score minimum is 7 and maximum is 35. Higher score means better outcome.
postoperative intervals through 5 years
Surgery Satisfaction Score
Time Frame: 1 and 5 years postoperative
Measures a patient's satisfaction with a surgical procedure based on questions about pain control and daily activities. Minimum score is 0. Maximum score is 10. Higher score means better outcome.
1 and 5 years postoperative
Forgotten Joint Score
Time Frame: postoperative intervals through 5 years
Measures a patient's awareness of their artificial knee joint. Minimum score is 0. Maximum score is 100. Higher score means better outcome.
postoperative intervals through 5 years
Knee Society Roentgenographic Evaluation and Scoring System
Time Frame: Through 2 years postoperative
Evaluates radiographic signs of device stability. 3 zones are assigned to evaluate the patella component. 5-7 zones are assigned to evaluate the tibia and femur components. Radiolucencies are evaluated for size, location, and progression over time. Changes in implant position and/or radiolucencies that are large, continuous, or progressive over time signify possible or impending implant failure.
Through 2 years postoperative
PROMIS Pain Interference Score - change from baseline
Time Frame: postoperative intervals through 5 years
The score measures how pain affects a person's life. The raw score minimum is 6 and maximum is 30. A lower score means a better outcome.
postoperative intervals through 5 years
PROMIS Physical Function Score - change from baseline
Time Frame: postoperative intervals through 5 years
The score measures a person's ability to perform activities. The raw score minimum is 11 and maximum is 72.5. A higher score means a better outcome.
postoperative intervals through 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Brian Schwartz, MD, Illinois Bone & Joint Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2025

Primary Completion (Estimated)

December 1, 2031

Study Completion (Estimated)

December 1, 2031

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

October 31, 2024

First Posted (Actual)

November 1, 2024

Study Record Updates

Last Update Posted (Actual)

June 10, 2025

Last Update Submitted That Met QC Criteria

June 5, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • LB24001-LSKUC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on total knee arthroplasty device

Subscribe